Market Access
Request to look further into NICE non-submissions in the fut...
Leela Barham looks at the discussion on non-submissions to the HTA body NICE, informed by the latest metrics for VPAG.
R&D
Changing Faces: Board of Director and Advisory Board hires, ...
Boardrooms, Advisory Boards, and governance teams saw plenty of activity in August.
Digital
Pharma brands face golden opportunity to extend supply chain...
People are ready for technology that verifies authenticity and provides helpful information directly from the medicinal product itself.
Patients
Why patient safety doesn't end at approval
Once a treatment becomes available to the public, protecting patient safety remains a priority throughout its time on the market.
Market Access
Sponsored
Due diligence: Identifying start-up risks & gaps
hVIVO's Consulting team discusses due diligence, a structured assessment process to evaluate an asset's risk, opportunities, and value drivers.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
